December 24, 2023
No Comments
This week witnessed an optimistic wave sweeping through the biotech sector with several key ETFs performing impressively. The SPDR S&P Biotech ETF (XBI) reported an
Blog
Category: Weekly Recap
December 17, 2023
No Comments
This week the SPDR S&P Biotech ETF (XBI) saw a nice growth of 8%, despite fund flows decreasing by $77.16 million for the week. The
December 10, 2023
No Comments
The SPDR S&P Biotech ETF (XBI) and iShares Nasdaq Biotechnology ETF (IBB) both rose by 2% this week, while the Direxion Daily S&P Biotech Bull ETF (LABU) increased by 8%. In corporate news, AbbVie (NYSE: ABBV) acquired Cerevel Therapeutics (NASDAQ: CERE). Also, amid an alarming obesity prevalence surge in the US, advancements in obesity treatments are being seen as key to mitigating soaring medical costs and prevalent health issues.
Categories
Newsletter
Signup our newsletter to get update information, product or insight.
Need more information about our service?
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
